These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 21554732)

  • 1. Expression of mutant alpha-synuclein modulates microglial phenotype in vitro.
    Rojanathammanee L; Murphy EJ; Combs CK
    J Neuroinflammation; 2011 May; 8():44. PubMed ID: 21554732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant.
    Hoenen C; Gustin A; Birck C; Kirchmeyer M; Beaume N; Felten P; Grandbarbe L; Heuschling P; Heurtaux T
    PLoS One; 2016; 11(9):e0162717. PubMed ID: 27622765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein expression modulates microglial activation phenotype.
    Austin SA; Floden AM; Murphy EJ; Combs CK
    J Neurosci; 2006 Oct; 26(41):10558-63. PubMed ID: 17035541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype.
    Yildirim-Balatan C; Fenyi A; Besnault P; Gomez L; Sepulveda-Diaz JE; Michel PP; Melki R; Hunot S
    J Neuroinflammation; 2024 Feb; 21(1):54. PubMed ID: 38383421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical role of Nramp1 in degrading α-synuclein oligomers in microglia under iron overload condition.
    Wu KC; Liou HH; Kao YH; Lee CY; Lin CJ
    Neurobiol Dis; 2017 Aug; 104():61-72. PubMed ID: 28476637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
    Zhang QS; Heng Y; Yuan YH; Chen NH
    Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein activates BV2 microglia dependent on its aggregation state.
    Hoffmann A; Ettle B; Bruno A; Kulinich A; Hoffmann AC; von Wittgenstein J; Winkler J; Xiang W; Schlachetzki JCM
    Biochem Biophys Res Commun; 2016 Oct; 479(4):881-886. PubMed ID: 27666480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Galectin-3 in α-synuclein-induced microglial activation.
    Boza-Serrano A; Reyes JF; Rey NL; Leffler H; Bousset L; Nilsson U; Brundin P; Venero JL; Burguillos MA; Deierborg T
    Acta Neuropathol Commun; 2014 Nov; 2():156. PubMed ID: 25387690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
    Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
    FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease.
    Zhang YN; Fan JK; Gu L; Yang HM; Zhan SQ; Zhang H
    J Neuroinflammation; 2021 Jan; 18(1):23. PubMed ID: 33461598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice.
    Gu XL; Long CX; Sun L; Xie C; Lin X; Cai H
    Mol Brain; 2010 Apr; 3():12. PubMed ID: 20409326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of alpha-synuclein modulates microglial phenotype in vitro.
    Austin SA; Rojanathammanee L; Golovko MY; Murphy EJ; Combs CK
    Neurochem Res; 2011 Jun; 36(6):994-1004. PubMed ID: 21384098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1.
    Li Y; Wang Y; Kou L; Yin S; Chi X; Sun Y; Wu J; Jin Z; Zhou Q; Zou W; Wang T; Xia Y
    CNS Neurosci Ther; 2024 May; 30(5):e14738. PubMed ID: 38702933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia.
    Fellner L; Irschick R; Schanda K; Reindl M; Klimaschewski L; Poewe W; Wenning GK; Stefanova N
    Glia; 2013 Mar; 61(3):349-60. PubMed ID: 23108585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein.
    Zhang W; Dallas S; Zhang D; Guo JP; Pang H; Wilson B; Miller DS; Chen B; Zhang W; McGeer PL; Hong JS; Zhang J
    Glia; 2007 Aug; 55(11):1178-88. PubMed ID: 17600340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2.
    Xia Y; Zhang G; Kou L; Yin S; Han C; Hu J; Wan F; Sun Y; Wu J; Li Y; Huang J; Xiong N; Zhang Z; Wang T
    Brain; 2021 Aug; 144(7):2024-2037. PubMed ID: 33792662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease.
    Shavali S; Combs CK; Ebadi M
    Neurochem Res; 2006 Jan; 31(1):85-94. PubMed ID: 16475001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease.
    Reynolds AD; Glanzer JG; Kadiu I; Ricardo-Dukelow M; Chaudhuri A; Ciborowski P; Cerny R; Gelman B; Thomas MP; Mosley RL; Gendelman HE
    J Neurochem; 2008 Mar; 104(6):1504-25. PubMed ID: 18036154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial LRRK2-mediated NFATc1 attenuates α-synuclein immunotoxicity in association with CX3CR1-induced migration and the lysosome-initiated degradation.
    Feng L; Lo H; Hong Z; Zheng J; Yan Y; Ye Z; Chen X; Pan X
    Glia; 2023 Sep; 71(9):2266-2284. PubMed ID: 37300531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson's disease.
    Lv QK; Tao KX; Wang XB; Yao XY; Pang MZ; Liu JY; Wang F; Liu CF
    Inflamm Res; 2023 Mar; 72(3):443-462. PubMed ID: 36598534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.